Carregant...

Novel therapies for relapsed/refractory aggressive lymphomas

Most patients with aggressive non-Hodgkin lymphoma will be cured with initial chemoimmunotherapy; however, most patients with relapsed disease will not be cured and will die as a result of their disease. In these cases, continued treatment with conventional chemotherapy is typically not of benefit a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hematology Am Soc Hematol Educ Program
Autor principal: Cohen, Jonathon B.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245978/
https://ncbi.nlm.nih.gov/pubmed/30504294
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!